Publication abstract
Subject class: Biotech, Life Sciences, Business Development, Funding
Impact of Global Healthcare Funding & Business Development on Life Science Research Sector ABA 305
Huckle D
Adams Business Associates: Global Library of World, National and Regional in depth Information and Market Analyses.
(337 pages & 149 figures, with Free Update to be provided in 2008). Price: GB £ 2,000 [single site licence], GB £ 2,900 [Multi-site licence)
Target audience: Chief executives, marketing and sales managers, business development managers, investors and analysts.
This is a primary report for the library of Global, National and Regional Analyses. It is an examination of the global Biotechnology and Life Science markets as of 2007 with projections out to 2010 based on the detailed data and analysis within the report.
This report examines the impact of funding for the sector not only from the conventional research sources but also the additional support that is given through research based Healthcare funding. The importance of all areas for the Reagents, Services and Equipment used in Healthcare and the other key Biotechnology fields are analysed and quantified. Detailed global market descriptions and quantification are given for the key market drivers of Life Science and Biotechnology.
Healthcare Sectors Pharmaceuticals, Vaccines, Diagnostics, BioTerrorism,
BioFuels & Energy
Industrial Bioplastics, Chemicals,
Waste, Energy & Environment
Agriculture
The business development within the Biotechnology sector is analysed in detail with special emphasis on the implementation of the Biotech Cluster approach across the world. The sources of funding to support the development of the sector with the different models used to combine Government, Venture Capital, Private and Industrial funding for Life Science research are analysed and quantified
In addition to detailing the products and their uses, the global markets are quantified and described in detail by region and country as well as by research segment. The major players in different parts of the market are examined with business and financial profiles of their global position and importance.
Written in Autumn 2007 this report will be updated with a Free Supplement in 2008 for all key charts and changes within the market. The commercial information will also be updated in the Supplement to ensure the Report retains its immediate utility.
The Life Science research market is strongly led by the impact of Drug Discovery and the need to develop Pharmaceutical procedures to enhance the speed of Drug Development, toxicology assessment (ADME/Tox) and cost efficiency. Trends and Issues, Market Segmentation by Country or Region, Applications or customers are explained within the multi layered Life Sciences sector.
The Report is now integrated within the Global Library of World, National and Regional in depth Information and Market Analyses where individual countries or regions are analysed to provide the fine detail for individual markets
close